Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    July 2018
  1. KOUTROS S, Baris D, Waddell R, Freeman LEB, et al
    Potential effect modifiers of the arsenic-bladder cancer risk relationship.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31720.
    PubMed     Text format     Abstract available


  2. LIN C, Travis RC, Appleby PN, Tipper S, et al
    Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31650.
    PubMed     Text format     Abstract available


    May 2018
  3. TELEKA S, Haggstrom C, Nagel G, Bjorge T, et al
    Risk of bladder cancer by disease severity in relation to metabolic factors and smoking; a prospective pooled cohort study of 800,000 men and women.
    Int J Cancer. 2018 May 14. doi: 10.1002/ijc.31597.
    PubMed     Text format     Abstract available


    February 2018
  4. LIU X, Cheng X, Liu X, He L, et al
    Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31323.
    PubMed     Text format     Abstract available


    January 2018
  5. INOUE-CHOI M, Hartge P, Liao LM, Caporaso N, et al
    Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort.
    Int J Cancer. 2018;142:271-280.
    PubMed     Text format     Abstract available


    December 2017
  6. YU Y, Jin H, Xu J, Gu J, et al
    XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIbeta mRNA stability.
    Int J Cancer. 2017 Dec 18. doi: 10.1002/ijc.31223.
    PubMed     Text format     Abstract available


  7. SHI X, Zhang X, Li J, Mo L, et al
    PD-1 blockade enhances the anti-tumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
    Int J Cancer. 2017 Dec 15. doi: 10.1002/ijc.31219.
    PubMed     Text format     Abstract available


  8. WESTHOFF E, Wu X, Kiemeney LA, Lerner SP, et al
    Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer.
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31214.
    PubMed     Text format     Abstract available


    September 2017
  9. RAVA M, Czachorowski MJ, Silverman D, Marquez M, et al
    Asthma status is associated with decreased risk of aggressive urothelial bladder cancer.
    Int J Cancer. 2017 Sep 22. doi: 10.1002/ijc.31066.
    PubMed     Text format     Abstract available


  10. MASAOKA H, Matsuo K, Sawada N, Yamaji T, et al
    Alcohol consumption and bladder cancer risk with or without the flushing response: The Japan Public Health Center-based Prospective Study.
    Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31028.
    PubMed     Text format     Abstract available


    July 2017
  11. BOTTERI E, Ferrari P, Roswall N, Tjonneland A, et al
    Alcohol consumption and risk of urothelial cell bladder cancer in the European Prospective Investigation into Cancer and Nutrition cohort.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30894.
    PubMed     Text format     Abstract available


    January 2017
  12. SOAVE A, Riethdorf S, Dahlem R, von Amsberg G, et al
    A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy.
    Int J Cancer. 2017;140:381-389.
    PubMed     Text format     Abstract available


    December 2016
  13. HADKHALE K, Martinsen JI, Weiderpass E, Kjaerheim K, et al
    Occupational exposure to solvents and bladder cancer: A population-based case control study in Nordic countries.
    Int J Cancer. 2016 Dec 29. doi: 10.1002/ijc.30593.
    PubMed     Text format     Abstract available


    June 2016
  14. ZHANG X, Zhang Y, Liu X, Liu T, et al
    Nested quantitative PCR approach for urinary cell-free EZH2 mRNA and its potential clinical application in bladder cancer.
    Int J Cancer. 2016 Jun 14. doi: 10.1002/ijc.30230.
    PubMed     Text format     Abstract available


  15. KISELYOV A, Bunimovich-Mendrazitsky S, Startsev V
    Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.
    Int J Cancer. 2016;138:2562-9.
    PubMed     Text format     Abstract available


    January 2016
  16. RODRIGUES D, Jeronimo C, Henrique R, Belo L, et al
    Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.
    Int J Cancer. 2016 Jan 25. doi: 10.1002/ijc.30016.
    PubMed     Text format     Abstract available


    December 2015
  17. WANG M, Du M, Ma L, Chu H, et al
    A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating a miR-140-5p binding site.
    Int J Cancer. 2015 Dec 22. doi: 10.1002/ijc.29978.
    PubMed     Text format     Abstract available


    October 2015
  18. MATULLO G, Naccarati A, Pardini B
    microRNA expression profiling in bladder cancer: The challenge of Next Generation Sequencing in tissues and biofluids.
    Int J Cancer. 2015 Oct 21. doi: 10.1002/ijc.29895.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: